The top five OTCs generated EUR74 million sales together in the past year.
The Nurofen brand is used for two product categories – pain relief products, EUR27 million sales and cold, flu and allergy relief products, which generated EUR11.1 million sales, according to Cegedim data. In all, Nurofen’s sales stood at EUR38 million in September 2015-August 2016.
Total OTC sales stood at more than EUR650 million, up 8.4% year-on-year. This was the only segment of the pharmaceutical market that posted growth, ZF has calculated from Cegedim data.
The rise in the sales of OTC is because of the greater purchasing power of Romanian consumers and the lack of regulations about the price of such products, said Razvan Bosinceanu, chairman of RASCI, the Romanian association of OTC producers.
(English version by Loredana Fratila-Cristescu)